The largest database of trusted experimental protocols

Ythdc1

Manufactured by GenePharma
Sourced in China

YTHDC1 is a protein that plays a role in the regulation of gene expression and RNA processing. It is a member of the YTH domain-containing protein family and has been found to bind to N6-methyladenosine (m6A) modifications in RNA. The YTHDC1 protein is involved in various cellular processes, including mRNA splicing, export, and stability.

Automatically generated - may contain errors

2 protocols using ythdc1

1

Genetic Manipulation of Gastric Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The normal gastric epithelial cell line GES-1 and GC cell lines (AGS, HGC27, MKN45, and SGC-7901) were purchased from the Cell Bank of the Chinese Academy of Science (Shanghai, China). All cell lines were incubated with RPMI 1640 medium (Solarbio, Beijing, China) supplemented with 10% FBS (Solarbio) in a humidified incubator at 37 °C containing 5% CO2.
FAM120A, WTAP, METTL3, METTL14, YTHDC1, SLCTA11, and PD-L1 knockdown and overexpression lentiviruses and their respective control vectors were generated by GenePharma (Shanghai, China). GC cells were inoculated into 6-well dishes and then infected with lentivirus at 60% confluence. Stable transfected cells were produced by treating cells with puromycin (4 μg/ml) for 2 weeks. The shRNA sequences are listed in Supplementary Table 2.
+ Open protocol
+ Expand
2

Gene Knockdown by RNAi Oligos

Check if the same lab product or an alternative is used in the 5 most similar protocols
For knockdown of gene expression, sets of three synthesized duplex RNAi oligos targeting human TTC22, WTAP, YTHDF1, YTHDF2, YTHDF3 or YTHDC1 mRNA were purchased from Gene Pharma (Shanghai, China; Table S1). Two siRNAs for RPL4 were purchased from RuiBo Bio (stB0001897A for siRPL4#1 and stB0001897B for siRPL4#2; Guangzhou, China). The LV3(H1/GFP& Puro)-shWTAP and empty vector plasmids were also constructed by GenePharma (Shanghai, China). Lentivirus particles of pLV-hU6-shRPL4 and the negative control were from SyngenTech Co., Ltd (pHS-ASR-1219 and pHS-ASR-LW429, Beijing, China). Cells at 70-80% con uence were transfected with siRNAs using X-tremeGENETM siRNA Transfection Reagent or with plasmids using X-tremeGENE HP DNA Transfection Reagent (Roche, Mannheim, Germany) according to the manufacturer's instructions. Successful knockdown of the target gene was con rmed by Western blot and qRT-PCR analyses. Scrambled siRNA sequences were used as negative controls.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!